PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, presenting promising enhancements across several health care and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, more trustworthy alternate for therapeutic use, specifica